Rifampicin resistant tuberculosis
Clinical trials for Rifampicin resistant tuberculosis explained in plain language.
Never miss a new study
Get alerted when new Rifampicin resistant tuberculosis trials appear
Sign up with your email to follow new studies for Rifampicin resistant tuberculosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 6-Month drug cocktail aims to tame resistant TB
Disease control Not yet recruitingThis phase 3 trial tests whether a 6-month combination of five drugs (bedaquiline, delamanid, delpazolid, levofloxacin, and pyrazinamide) works as well as standard treatment for rifampicin-resistant tuberculosis in adults and adolescents aged 15 and older in South Africa. The stu…
Matched conditions: RIFAMPICIN RESISTANT TUBERCULOSIS
Phase 3 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope against Drug-Resistant TB: phase II trial launches
Disease control Not yet recruitingThis study tests whether adding acetohydroxamic acid (AHA) to a short-course antibiotic regimen can safely and effectively treat multidrug-resistant tuberculosis (MDR-TB). About 120 adults with confirmed MDR-TB will receive either AHA or a placebo alongside standard drugs. The go…
Matched conditions: RIFAMPICIN RESISTANT TUBERCULOSIS
Phase 2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New 9-Month pill regimen could tackle Drug-Resistant TB
Disease control Not yet recruitingThis phase 3 trial tests a 9-month, all-oral combination of four drugs (BLMZ) for people aged 12 and older with rifampicin-resistant tuberculosis. The goal is to see if this shorter regimen leads to a cure without the need for injections. Participants take the pills daily or week…
Matched conditions: RIFAMPICIN RESISTANT TUBERCULOSIS
Phase 3 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Could a 6-Month pill combo beat Drug-Resistant TB?
Disease control Not yet recruitingThis study tests whether a 6-month combination of four drugs (bedaquiline, delamanid, linezolid, and levofloxacin) works as well as the standard longer treatment for drug-resistant tuberculosis. Fifty-two adults in Hubei, China will be randomly assigned to either the short or sta…
Matched conditions: RIFAMPICIN RESISTANT TUBERCULOSIS
Sponsor: Wuhan Pulmonary Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Sputum DNA test aims to outsmart Drug-Resistant TB
Diagnosis Not yet recruitingThis trial tests a new DNA test that reads drug resistance directly from sputum samples in people with multidrug-resistant tuberculosis (MDR-TB). The goal is to see if this test helps doctors prescribe at least five effective drugs within 14 days of diagnosis, compared to current…
Matched conditions: RIFAMPICIN RESISTANT TUBERCULOSIS
Sponsor: University of Cape Town • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC